New brain scans aim to spot inflammation in Alzheimer's and Parkinson's
NCT ID NCT04396873
First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study uses special PET scans to measure inflammation in the brains of people with Alzheimer's, Parkinson's, ALS, and other neurodegenerative diseases. Researchers will compare these scans to those from healthy volunteers to see if inflammation levels differ. The goal is to develop better tools for understanding and tracking these diseases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 11C-MC1, 11C-PS13, and 18F-florbetaben (radioactive tracers injected for PET imaging)
- What this could lead to
- If successful, this could lead to better ways to detect and monitor brain inflammation in neurodegenerative diseases, aiding diagnosis and treatment development.
- What could go wrong
- This is an early-phase imaging study, not a treatment trial. It may not find clear differences between patients and healthy volunteers, and results may not directly improve patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your brain help unlock Alzheimer's secrets?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Can a gene therapy clear the toxic tau tangle in Alzheimer's?
- Can a Voice-Based app map healthy brain aging across 80 years?